Please Note:
This profile was automatically generated using 5 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 5 references found on the Internet. This information has not been verified. Learn more...
Web References
-
1. Nemours.org - Research - Wilmington Campus Research Seminar Series
www.nemours.org/internet?url=n - [Cached]Published on: 12/31/2003 Last Visited: 7/31/2004
June 28: "Lis1 and Cytoplasmic Dynein in Development and Disease" Presented by Deanna S. Smith, Ph.D., Assistant Professor, Department of Biological Sciences and the Center for Colon Cancer Research, University of South Carolina, Columbia, SC
Special Research Seminar -
2. Prevent Cancer Foundation
preventcancer.org/research2c.a - [Cached]Published on: 11/18/2007 Last Visited: 1/24/2008
Deanna Smith, Ph.D. University of South Carolina
Drs. Hebbar and Smith are testing the effects of common Type 2 diabetes medications on preventing or encouraging the incidence of colon cancer. The cells that line the colon are unusual because they are exposed to ingested substances in our diet. These cells can also be directly influenced by oral medications and this unique feature offers opportunities for chemoprevention. Drs. Hebbar and Smith are investigating one type of drug, called "a PPAR-activating drug," to determine its cancer preventive abilities. -
3. Nemours.org - Research - Wilmington Campus Research Seminar Series
www.nemours.com/internet?url=n - [Cached]Published on: 12/19/2003 Last Visited: 7/14/2004
June 28: "Lis1 and Cytoplasmic Dynein in Development and Disease" Presented by Deanna S. Smith, Ph.D., Assistant Professor, Department of Biological Sciences and the Center for Colon Cancer Research, University of South Carolina, Columbia, SC
Special Research Seminar
